Calendar

Apr 27, 2026phase 1 completion106d agoCTI Clinical Trial and Consulting Services Australia Pty Ltd — PTC-844 (Phase I Trial Completion)PTC-844

Therapy area: Immunology. Indication: Unspecified Immunological Disorders

full page →PTC-844 →source: globaldata

Apr 27, 2026phase 1 completion106d agoFortrea Holdings Inc — balinatunfib (Phase I Trial Completion)balinatunfib

Therapy area: Gastrointestinal, Immunology. Indication: Crohn's Disease (Regional Enteritis), Inflammatory Bowel Disease, Plaque Psoriasis (Psoriasis Vulgaris), Rheumatoid Arthritis, Ulcerative Colitis

full page →balinatunfib →source: globaldata

Apr 27, 2026phase 1 initiation106d agoNational Heart Lung and Blood Institute — fostamatinib (Phase I Trial Initiation)fostamatinib

Therapy area: Immunology. Indication: Liver Transplant Rejection

full page →fostamatinib →source: globaldata

Apr 27, 2026phase 3 initiation106d agoUniversity of Thessaly — abatacept (Phase III Trial Initiation)abatacept

Therapy area: Immunology. Indication: Rheumatoid Arthritis

full page →abatacept →source: globaldata

Week of Apr 27, 2026